Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Higher-risk people are shunning colon cancer screens

26.05.2008
It is difficult to make colon cancer screening effective, according to a follow-up study conducted by the Swedish medical university Karolinska Institutet of a screening programme from 1999. Many of the people who would probably have benefited most from the survey opted not to take part.

An acknowledged problem in public health surveys is that those who take part are generally more health conscious and healthier than those who do not. If this is also true of colon cancer screening, it means, at worst, that the people at greatest risk of developing the disease are not being screened, even though they would benefit most from the procedure.

A new study from Karolinska Institutet has confirmed these fears. Nine years ago, a team of researchers invited 2,000 people between the ages of 59 and 61 to take part in a colon cancer screening programme. Thirty-nine per cent of them accepted, but 61 per cent chose not to. A follow-up of these two groups has now shown that a larger percentage of the non-participants have since developed colon cancer or died, either from colon cancer or other diseases, compared with the participants.

“We do not think that the difference in incidences of cancer and death between the two groups is due to any effect the screening might have had, but believe it was down to the selection of people who took part,” says Johannes Blom, one of the researchers behind the study. “What we have here is the self-selection of more health conscious and healthier people , who perhaps don’t benefit as much from taking part.”

The team believes that those who opted out of the programme have less healthy lifestyles. This is supported by the findings that more of the non-participants have developed other forms of smoking-related cancer and that they run more than double the risk of dying from cardiovascular disease.

“If higher-risk people choose not to take part, public screening programmes will become very cost inefficient,” says Dr Blom. “One of the greatest challenges is therefore to encourage participation, so that the less motivated are also screened.”

On 1 January, the Stockholm County Council became the first health authority in Sweden to launch a screening programme for colon cancer.

Katarina Sternudd | alfa
Further information:
http://www.ki.se

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>